Cell Sciences
Private Company
Funding information not available
Overview
Founded in 1992 and headquartered in Canton, USA, Cell Sciences operates as a specialized distributor and provider of essential research reagents. The company's business model is centered on supplying a broad catalog of over 7,000 proteins, peptides, and antibodies, alongside assay kits and biological samples, to the global life science research community. It acts as a distributor for other manufacturers while also promoting its own branded products and technical content, positioning itself as a resource for researchers in immunology, oncology, and infectious disease. As a private company, it appears to be revenue-generating through direct sales and distribution.
Technology Platform
Curated portfolio of research reagents including biologically active antibodies, recombinant proteins (e.g., HEK293-expressed), immunoassay kits (ELISA/ELISPOT), and biological samples (tissues, lysates). Focus on product validation, compatibility, and supporting functional research.
Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive life science reagents market, competing against global leaders like Thermo Fisher, Abcam, and Bio-Techne, as well as many specialized antibody/protein companies. Differentiates through a focused catalog, emphasis on biologically active reagents, and acting as a value-added distributor.